Theralase approved for Europe

February 07, 2011
Jan 31, Toronto, Ont. - Theralase Technologies Inc. is pleased to announce that it has been granted notified body approval to place the CE mark on its TLC-1000 series of products, clearing the way for sale of its laser products throughout all 30 member states of the European Union (EU).

CE approval is a mandatory approval stage in the sale of products to European Union (EU) countries. It serves as a declaration that the product meets EU consumer safety, health and environmental requirements.

“Achieving CE approval allows Theralase another opportunity to expand the sale of our medical lasers internationally", stated Roger Dumoulin-White, President and CEO of Theralase Technologies Inc. "By possessing CE approval, in addition to our Health Canada, FDA and certain Latin American and Asian approvals, we are now able to sell our medical lasers to over 63 per cent of the worldmarket (as measured by GDP). This presents a great opportunity for Theralase to expand our revenue generation capability beyond our present markets."

For more information visit the corporate or regulatorywebsite at or

Add comment

Security code

Subscription Centre

New Subscription
Already a Subscriber
Customer Service
View Digital Magazine Renew

Most Popular


We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.